Designing, synthesis and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4,5-dihydro-pyrazol-1-yl] benzenesulfonamides
Özet
In this study, 4-[3-(4-hydroxyphenyl)-5-aryl-4,5-dihydro-pyrazol-1-yl] benzenesulfonamide (1-9) types compounds were synthesized and their chemical structures were confirmed by H-1 NMR, C-13 NMR and HRMS spectra. Cytotoxic and carbonic anhydrase (CA) inhibitory effects of the compounds were investigated. Cytotoxicity experiments pointed out that compound 4, (4-[5-(4-chlorophenyl)-3-(4-hydroxyphenyl)-4,5dihydro- pyrazol-1-yl] benzenesulfonamide), exerting the highest tumor selectivity (TS) and potency selectivity expression (PSE) values, can be considered as a lead compound of this study in terms of development of novel anticancer agents. All synthesized sulfonamides showed a good inhibition profile on hCA IX and XII in the range of 53.5-923nM and 6.2-95 nM, respectively. These compounds were 2.5-13.4 times more selective for the inhibition of hCA XII versus hCA IX, except compound 2 which had similar inhibitory action towards both isoenzymes.
Anahtar kelimeler
Atıf için künye
Gül, H. İ., Mete, E., EREN, S. E., SAKAGAMI, H., YAMALI, C., & SUPURAN, C. T. (2017). Designing, synthesis and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4,5-dihydro-pyrazol-1-yl] benzenesulfonamides. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 32(1), 169–175. https://doi.org/10.1080/14756366.2016.1243536
BibTeX
@article{gul2017-19872,
author = {Gül, Halise İnci and Mete, Ebru and EREN, Sakip Emre and SAKAGAMI, Hiroshi and YAMALI, Cem and SUPURAN, Claudiu T.},
title = {Designing, synthesis and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4,5-dihydro-pyrazol-1-yl] benzenesulfonamides},
journal = {JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY},
year = {2017},
volume = {32},
number = {1},
pages = {169--175},
issn = {1475-6366},
doi = {10.1080/14756366.2016.1243536},
url = {https://akademik.atauni.edu.tr/yayinlar/19872-designing-synthesis-and-bioactivities-of-4-3-4-hydroxyphenyl-5-aryl-45-dihydro}
}